Morgan Stanley analyst Joshua Pokrzywinski maintains Flowserve (NYSE:FLS) with a Equal-Weight and lowers the price target from $33 to $31.
Mizuho Maintains Buy on Assembly Biosciences, Lowers Price Target to $3
Mizuho analyst Salim Syed maintains Assembly Biosciences (NASDAQ:ASMB) with a Buy and lowers the price target from $14 to $3.